Ovid Therapeutics (OVID) - 2023 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) Delaware 46-5270895 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification Number) 441 Ninth Avenue, 14th Floor New York, New York 10001 (Address of principal executive offices) (Zip Code) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECU ...